Clinical trial · Observational
Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada
NCT02705833CI-TRIAL-00027138completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary objective of the study is to characterize the medical management of squamous cell carcinoma head and neck (SCCHN) patients diagnosed with recurrent/metastatic (R/M) disease (between 01July2013 and 30 June 2014) in the real-world setting.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Population with R/M SCCHN
- description
- Recurrent/Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN) patients diagnosed between 01July2013 and 30June2014, alive or deceased, at the time of data collection
Primary outcomes (5)
- measure
- Best Therapy Response defined as Complete Response (CR), Partial Response (PR), Stable Disease (SD) or Progressive Disease (PD) based on physician's assessment for each therapy regimen
- timeFrame
- approximately 12 months
- measure
- Overall Survival(OS) of patients with an Index diagnosis of R/M SCCHN
- timeFrame
- approximately 12 months
- measure
- Progression-Free Survival(PFS) of patients with an Index diagnosis of R/M SCCHN
- timeFrame
- approximately 12 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patient (18 years old or older) with a confirmed diagnosis or R/M head and neck, may be living or deceased at time of enrollment in the study * Diagnosis of R/M head and neck cancer between 01July2013 and 30June2014 (study index period) Exclusion Criteria: * If female patient, pregnant or lactating between 01July2013 and 30June2014 * Enrolled in cancer treatment-clinical trials since diagnosis of R/M head and neck cancer during the study index period
References
Publications (0)
Data not yet available
No reference posted for this study.